After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
GSK Plc ADR is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of GSK Plc ADR is $86.83B. A total of 3.04 million shares were traded on the day, compared to an average of 3.51M shares.
In the most recent transaction, GSK plc bought 3,300,000 shares of GSK for 5.00 per share on Dec 07 ’23. After the transaction, the 10% Owner now owns 13,983,761 company shares.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. GSK Plc ADR pays an annual dividend of $1.47, resulting in a dividend yield of 3.43%, and it has a price to earnings (P/E) ratio of 14.30. GSK’s most recent ex-dividend date was 2/22/2024 when it declared a $0.3564 quarterly dividend that was paid in cash on 4/11/2024. Previously, the company paid the dividend on 1/11/2024 with an ex-dividend date of 11/16/2023. The GSK stock dividend was $0.3398 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, GSK has a high of $43.84 and a low of $33.33.
As of this writing, GSK has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0. The company reported an EPS of $1.28 in the last quarter, which was 12.30% higher than expectations of $1.14.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GSK’s latest balance sheet shows that the firm has $4.13B in Cash & Short Term Investments as of fiscal 2021. There were $24.17B in debt and $23.67B in liabilities at the time. Its Book Value Per Share was $8.39, while its Total Shareholder’s Equity was $21.34B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GSK is Buy with a score of 3.11.
